ProPublica

Journalism in the Public Interest

Cancel
Dollars for Docs logo

Dollars for Docs

IN COOPERATION WITH

In recent years, drug companies have started releasing details of the payments they make to doctors and other health professionals for promotional talks, research and consulting. As of 2013, 17 companies published the information, most because of legal settlements. Use this tool to search for payments. Read more about the data »

Interested in downloading the data? Go to the ProPublica Data Store.

Has Your Health Professional Received Drug Company Money?

Example searches: Klein, Duke University, Miami

With 3.4 Million records, this database represents:

Cash $4 billion

in disclosed payments

Pharma 17

companies

Pie-2 ~ 50%

of total market share

Payments in Your State

Click on a state to see payments made to practitioners and institutions there. See notes below.

State Total
Alabama $50,260,643
Alaska $1,042,805
Arizona $62,702,011
Arkansas $21,362,396
California $452,673,630
Colorado $58,312,319
Connecticut $52,273,720
Delaware $5,939,477
District of Columbia $15,146,145
Florida $336,830,659
Georgia $113,339,486
Hawaii $5,671,182
Idaho $15,393,785
Illinois $123,171,947
Indiana $73,338,331
Iowa $17,544,201
Kansas $49,081,450
Kentucky $46,085,189
Louisiana $40,364,357
Maine $6,585,519
Maryland $100,458,435
Massachusetts $190,604,686
Michigan $87,404,867
Minnesota $52,501,755
Mississippi $15,288,537
Missouri $90,568,929
Montana $5,336,423
Nebraska $52,843,021
Nevada $24,449,643
New Hampshire $9,522,413
New Jersey $96,371,463
New Mexico $12,423,183
New York $253,076,249
North Carolina $151,214,448
North Dakota $7,186,285
Ohio $151,053,182
Oklahoma $35,330,524
Oregon $38,505,013
Pennsylvania $166,968,149
Rhode Island $21,157,644
South Carolina $76,956,857
South Dakota $5,454,726
Tennessee $81,922,051
Texas $311,162,364
Utah $48,013,780
Vermont $3,953,952
Virginia $62,016,456
Washington $63,504,918
West Virginia $10,652,924
Wisconsin $41,852,218
Wyoming $596,677
Puerto Rico $21,831,197
[Unknown State] $1,226,608

Company Disclosures

The totals listed here cover different time periods and spending categories, and aren't directly comparable. See notes below. See what each company discloses »

Company Total Disclosed
AbbVie
Disclosed: July 2012 to Dec. 2013
$62.6M
Allergan
Disclosed: July 2011 to Dec. 2013
Ranges*
Amgen
Disclosed: Jan. to Dec. 2013
$42M
AstraZeneca
Disclosed: Jan. 2010 to Dec. 2013
$428.2M
Boehringer Ingelheim
Disclosed: Jan. to Dec. 2013
$99.2M
Cephalon
Disclosed: Jan. 2009 to June 2013
$99.6M
Eli Lilly
Disclosed: Jan. 2009 to Dec. 2013
$811.7M
EMD Serono
Disclosed: Jan. 2011 to Dec. 2013
$8.1M
Forest
Disclosed: Jan. 2012 to Dec. 2013
$208.8M
GlaxoSmithKline
Disclosed: April 2009 to Dec. 2013
$437.9M
Johnson & Johnson
Disclosed: Jan. 2010 to Dec. 2013
$100.5M
Merck
Disclosed: July 2009 to Dec. 2013
$499.7M
Novartis
Disclosed: Oct. 2010 to Dec. 2013
$198.6M
Pfizer
Disclosed: July 2009 to Dec. 2013
$745.2M
UCB
Disclosed: Jan. 2012 to Dec. 2013
$56.5M
Valeant
Disclosed: Jan. 10, 2010 to Dec. 2013
Ranges*
ViiV
Disclosed: Jan. 2010 to Dec. 2013
$38.6M

Notes: Companies report different types of payments for different time periods. Payments made after December 2013 are not reflected on this website. Because they are reported in ranges, some of Valeant's payments and all of Allergan's payments are excluded from state and national totals. No payments are listed for Novartis from Oct. 1, 2011 to Dec. 31, 2011 or for Valeant between Sept. 27, 2010 and Jan. 1, 2011.

Local Stories Based on This Data

See recent stories that use our data below. Interested in being notified when we update our app? Find out how.

Our Stories

20140929-dollars-for-docs-300x200_1

What We’ve Learned from Four Years of Diving into Dollars for Docs

Payments from pharmaceutical companies touch hundreds of thousands of doctors. The 17 companies we’ve tracked spent $1.4 billion in 2013 alone. Here are our top five takeaways from following all that money.

As Full Disclosure Nears, Doctors’ Pay for Drug Talks Plummets

As transparency increases and blockbuster drugs lose patent protection, drug companies have dramatically scaled back payments to doctors for promotional talks.

Dollars for Docs Mints a Millionaire

New data show drugmakers' payments to hundreds of thousands of doctors, and some have made well over $500,000.

Background Stories


Reporters, Use Our Data

Have questions about how you can best use Dollars for Docs for your own localized reporting? Contact Nicole Collins Bronzan at communications@propublica.org.

Additional reporting and development by Jason Das, Liz Day, David Frackman, Jennifer LaFleur, Jeff Larson, Dan Nguyen, Mike Tigas and Sisi Wei. Pharmacy icon from The Noun Project. The 2012 market share for the companies included in this tool was calculated using data from IMS Health, a health care information company.

Add Dollars for Docs to Your Site

We've created a Dollars for Docs widget that you can embed on any site. See it in action below, and click the "embed button" to get the code.